BioNexus Gene Lab Corp (BGLC) Live Share Price, Invest From India

BioNexus Gene Lab Corp Stock Performance

as on July 15, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.55
Day's Price Range
$1.75
$1.64
5.49%
Downside
6.71%
Upside
52 Week's Low
52 Week's High
$1.07
52-Week Price Range
$8.98
$1.64
34.76%
Downside
447.56%
Upside

BioNexus Gene Lab Corp share price movements today

Previous Close: $1.74
Open: $1.75
Volume: 198.6K
Day's Low - High: $1.55 - $1.75
52 Week Low - High: $1.07 - $8.98

BioNexus Gene Lab Corp Historical Returns

1 Month Return: -34.4 %
3 Month Return: -24.77 %
1 Year Return: -56.27 %
3 Year Return: -98.73 %
5 Year Return: 0 %

BioNexus Gene Lab Corp Stock Fundamentals & Key Indicators

Check BioNexus Gene Lab Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-36.62%

BioNexus Gene Lab Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioNexus Gene Lab Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BioNexus Gene Lab Corp	NA	$4.2M	NA	NA	-54.70%	NA
Ecolab Inc.	HOLD	$77.2B	25.7%	37.17	12.80%	1.01%
Linde plc	BUY	$242.3B	78.92%	34.71	20.44%	1.15%
NOVONESIS (NOVOZYMES) B (ADR)	NA	$30.3B	NA	44.56	14.21%	1.54%
The Sherwin-Williams Company	BUY	$82.4B	17.69%	32.05	10.86%	0.95%

See all

Stock Returns calculator for BioNexus Gene Lab Corp Stock including INR - Dollar returns

The BioNexus Gene Lab Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BioNexus Gene Lab Corp investment value today

Current value as on today

₹48,906

Returns

-₹51,094

(-51.09%)

Returns from BioNexus Gene Lab Corp Stock

-₹56,267 (-56.27%)

Dollar Impact

₹5,173 (+5.17%)

Indian Investors' Interest in BioNexus Gene Lab Corp Stock

Search interest for BioNexus Gene Lab Corp Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 15, 2026 to July 15, 2026

Change:-46% versus previous 30 day period

BioNexus Gene Lab Corp Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	2	1	2	2	2	2	2	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	0	0	-1	0	0	0	0	-1	0
EBITDA	-	0	0	-1	-	0	0	0	-	0
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	0	0	0	-1	0	0	0	0	-1	0
Income Tax Expense	-	0	0	0	-	0	-	-	-	-
Net Income	0	0	0	-1	0	0	0	0	-1	0
Net Profit Margin	13.52%	-4.36%	10.08%	-51.15%	-13.80%	-29.17%	-27.26%	-27.87%	-214.18%	-2379.72%

BioNexus Gene Lab Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	11	13	10	9	9	7
Gross Profit	0	0	0	1	2	1	1	1	1
Operating Income	0	0	0	1	1	0	-2	-1	-3
EBITDA	0	0	0	1	1	0	-2	-1	-2
Interest Expense	-	-	-	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	0	0	0	1	1	0	-2	-1	-2
Income Tax Expense	0	0	0	0	0	0	0	0	-
Net Income	0	0	0	1	0	0	-2	-1	-2
Net Profit Margin	-114.92%	12.46%	-194.14%	9.61%	5.62%	-3.26%	-26.91%	-16.81%	-40.20%

BioNexus Gene Lab Corp Quarterly Cash Flow

All numbers in Millions USD

	Sep 2024	Dec 2024	Sep 2025	Dec 2025
Net Income	-1	0	0	-1
Operating Cash Flow	-1	0	-1	0
Investing Cash Flow	0	-	0	-
Financing Cash Flow	0	0	0	0
Change in Cash	-1	0	0	1

BioNexus Gene Lab Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2020	Dec 2023	Dec 2024	Dec 2025
Net Income	0	1	-2	-1	-2
Operating Cash Flow	0	0	-1	-2	-1
Investing Cash Flow	-5	1	-1	0	0
Financing Cash Flow	5	0	6	0	0
Change in Cash	0	1	3	-1	0

Global Institutional Holdings in BioNexus Gene Lab Corp

Funds	Holdings
DRW Securities, LLC	0%
UBS Group AG	0.01%
Wells Fargo & Co	0%

Insights on BioNexus Gene Lab Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.03M → -543.57K (in $), with an average increase of 90.6% per quarter
NO EFFECT
Against Peers
In the last 3 years, Ecolab, Inc. has given 38.0% return, outperforming this stock by 136.7%
NO EFFECT
Against Peers
In the last 1 year, Linde plc Ordinary Shares has given 13.5% return, outperforming this stock by 69.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, BGLC stock has moved down by -15.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.54M → 22.84K (in $), with an average decrease of 88.1% per quarter

About BioNexus Gene Lab Corp

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Organisation	BioNexus Gene Lab Corp
Headquarters	Menara UOA Bangsar, Kuala Lumpur, Malaysia, 59000
Industry	Specialty Chemicals
CEO	Mr. Su-Leng Tan
E-voting on shares	Click here to vote

Key Management of BioNexus Gene Lab Corp

Name	Title
Ms. Set Fui Chong	Chief Financial Officer
Mr. Kwan Wah Chan	Marketing Manager
Mr. Too Kam Tham	Managing Director
Mr. Su-Leng Tan	CEO, President, Secretary & Director

FAQs

What is BioNexus Gene Lab Corp share price today?

BioNexus Gene Lab Corp share price today is $1.64 as on July 15, 2026 at 8:46 am IST at the close of the market. BioNexus Gene Lab Corp share today touched a day high of $1.75 and a low of $1.55.

What is the 52 week high and 52 week low for BioNexus Gene Lab Corp share?

BioNexus Gene Lab Corp share touched a 52 week high of $8.98 on July 30, 2025 and a 52 week low of $1.07 on June 10, 2026. BioNexus Gene Lab Corp stock price today i.e. July 15, 2026 at 8:46 am IST is closed at $1.64,which is 81.74% down from its 52 week high and 53.27% up from its 52 week low.

What is BioNexus Gene Lab Corp's market capitalisation today?

BioNexus Gene Lab Corp market capitalisation is $0.00T as on July 15, 2026 at 8:46 am IST.

How to invest in BioNexus Gene Lab Corp Stock (BGLC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BioNexus Gene Lab Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioNexus Gene Lab Corp Shares that will get you 0.9146 shares as per BioNexus Gene Lab Corp share price of $1.64 per share as on July 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy BioNexus Gene Lab Corp Stock (BGLC) from India?

Indian investors can start investing in BioNexus Gene Lab Corp (BGLC) shares with as little as ₹96.19 or $1 (as of July 15, 2026 at 1:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹961.90 in BioNexus Gene Lab Corp stock (as per the Rupee-Dollar exchange rate as on July 15, 2026 at 1:41 pm IST). Based on BioNexus Gene Lab Corp share’s latest price of $1.64 as on July 15, 2026 at 8:46 am IST, you will get 6.0976 shares of BioNexus Gene Lab Corp. Learn more about fractional shares .